nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—SLC22A11—Methotrexate—lymphatic system cancer	0.123	0.181	CbGbCtD
Ketoprofen—SLC22A7—Methotrexate—lymphatic system cancer	0.117	0.173	CbGbCtD
Ketoprofen—ABCC4—Methotrexate—lymphatic system cancer	0.114	0.169	CbGbCtD
Ketoprofen—SLCO1A2—Methotrexate—lymphatic system cancer	0.0818	0.121	CbGbCtD
Ketoprofen—CYP2C9—Teniposide—lymphatic system cancer	0.0782	0.116	CbGbCtD
Ketoprofen—SLC22A8—Methotrexate—lymphatic system cancer	0.0713	0.105	CbGbCtD
Ketoprofen—SLC22A6—Methotrexate—lymphatic system cancer	0.0496	0.0734	CbGbCtD
Ketoprofen—ALB—Methotrexate—lymphatic system cancer	0.0423	0.0625	CbGbCtD
Ketoprofen—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000853	0.00264	CcSEcCtD
Ketoprofen—Chills—Bleomycin—lymphatic system cancer	0.000848	0.00262	CcSEcCtD
Ketoprofen—Skin discolouration—Methotrexate—lymphatic system cancer	0.000843	0.00261	CcSEcCtD
Ketoprofen—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.000843	0.0026	CcSEcCtD
Ketoprofen—Sweating—Vincristine—lymphatic system cancer	0.000841	0.0026	CcSEcCtD
Ketoprofen—Renal failure—Mitoxantrone—lymphatic system cancer	0.00084	0.0026	CcSEcCtD
Ketoprofen—Nausea—Mechlorethamine—lymphatic system cancer	0.00084	0.0026	CcSEcCtD
Ketoprofen—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.000838	0.00259	CcSEcCtD
Ketoprofen—Alopecia—Bleomycin—lymphatic system cancer	0.000836	0.00258	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000835	0.00258	CcSEcCtD
Ketoprofen—Stomatitis—Mitoxantrone—lymphatic system cancer	0.000833	0.00258	CcSEcCtD
Ketoprofen—Jaundice—Mitoxantrone—lymphatic system cancer	0.000833	0.00258	CcSEcCtD
Ketoprofen—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.000831	0.00257	CcSEcCtD
Ketoprofen—Urticaria—Teniposide—lymphatic system cancer	0.000828	0.00256	CcSEcCtD
Ketoprofen—Abdominal pain—Teniposide—lymphatic system cancer	0.000824	0.00255	CcSEcCtD
Ketoprofen—Erythema—Bleomycin—lymphatic system cancer	0.000823	0.00254	CcSEcCtD
Ketoprofen—Paraesthesia—Fludarabine—lymphatic system cancer	0.000823	0.00254	CcSEcCtD
Ketoprofen—Hallucination—Carmustine—lymphatic system cancer	0.000821	0.00254	CcSEcCtD
Ketoprofen—Sweating—Mitoxantrone—lymphatic system cancer	0.00082	0.00253	CcSEcCtD
Ketoprofen—Dyspnoea—Fludarabine—lymphatic system cancer	0.000817	0.00252	CcSEcCtD
Ketoprofen—Haematuria—Mitoxantrone—lymphatic system cancer	0.000815	0.00252	CcSEcCtD
Ketoprofen—Dyspepsia—Fludarabine—lymphatic system cancer	0.000807	0.00249	CcSEcCtD
Ketoprofen—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000798	0.00247	CcSEcCtD
Ketoprofen—Decreased appetite—Fludarabine—lymphatic system cancer	0.000797	0.00246	CcSEcCtD
Ketoprofen—Visual impairment—Carmustine—lymphatic system cancer	0.000795	0.00246	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000791	0.00245	CcSEcCtD
Ketoprofen—Fatigue—Fludarabine—lymphatic system cancer	0.00079	0.00244	CcSEcCtD
Ketoprofen—Hallucination—Vincristine—lymphatic system cancer	0.000784	0.00242	CcSEcCtD
Ketoprofen—Constipation—Fludarabine—lymphatic system cancer	0.000784	0.00242	CcSEcCtD
Ketoprofen—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000769	0.00238	CcSEcCtD
Ketoprofen—Hypersensitivity—Teniposide—lymphatic system cancer	0.000768	0.00237	CcSEcCtD
Ketoprofen—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000767	0.00237	CcSEcCtD
Ketoprofen—Flushing—Carmustine—lymphatic system cancer	0.000766	0.00237	CcSEcCtD
Ketoprofen—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000764	0.00236	CcSEcCtD
Ketoprofen—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000762	0.00235	CcSEcCtD
Ketoprofen—Anaemia—Bleomycin—lymphatic system cancer	0.000761	0.00235	CcSEcCtD
Ketoprofen—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000755	0.00233	CcSEcCtD
Ketoprofen—Asthenia—Teniposide—lymphatic system cancer	0.000748	0.00231	CcSEcCtD
Ketoprofen—Melaena—Methotrexate—lymphatic system cancer	0.000744	0.0023	CcSEcCtD
Ketoprofen—Malaise—Bleomycin—lymphatic system cancer	0.000742	0.00229	CcSEcCtD
Ketoprofen—Pruritus—Teniposide—lymphatic system cancer	0.000738	0.00228	CcSEcCtD
Ketoprofen—Arrhythmia—Carmustine—lymphatic system cancer	0.000737	0.00228	CcSEcCtD
Ketoprofen—Alopecia—Carmustine—lymphatic system cancer	0.000729	0.00225	CcSEcCtD
Ketoprofen—Erythema—Carmustine—lymphatic system cancer	0.000719	0.00222	CcSEcCtD
Ketoprofen—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000715	0.00221	CcSEcCtD
Ketoprofen—Diarrhoea—Teniposide—lymphatic system cancer	0.000713	0.0022	CcSEcCtD
Ketoprofen—Myalgia—Bleomycin—lymphatic system cancer	0.000701	0.00217	CcSEcCtD
Ketoprofen—Alopecia—Vincristine—lymphatic system cancer	0.000696	0.00215	CcSEcCtD
Ketoprofen—Discomfort—Bleomycin—lymphatic system cancer	0.000692	0.00214	CcSEcCtD
Ketoprofen—Chills—Mitoxantrone—lymphatic system cancer	0.000689	0.00213	CcSEcCtD
Ketoprofen—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000688	0.00213	CcSEcCtD
Ketoprofen—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000686	0.00212	CcSEcCtD
Ketoprofen—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000681	0.00211	CcSEcCtD
Ketoprofen—Alopecia—Mitoxantrone—lymphatic system cancer	0.000678	0.0021	CcSEcCtD
Ketoprofen—Confusional state—Bleomycin—lymphatic system cancer	0.000677	0.00209	CcSEcCtD
Ketoprofen—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000675	0.00209	CcSEcCtD
Ketoprofen—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000672	0.00208	CcSEcCtD
Ketoprofen—Oedema—Bleomycin—lymphatic system cancer	0.000672	0.00208	CcSEcCtD
Ketoprofen—Erythema—Mitoxantrone—lymphatic system cancer	0.000668	0.00206	CcSEcCtD
Ketoprofen—Infection—Bleomycin—lymphatic system cancer	0.000667	0.00206	CcSEcCtD
Ketoprofen—Anaemia—Carmustine—lymphatic system cancer	0.000664	0.00205	CcSEcCtD
Ketoprofen—Vomiting—Teniposide—lymphatic system cancer	0.000663	0.00205	CcSEcCtD
Ketoprofen—Sepsis—Methotrexate—lymphatic system cancer	0.000661	0.00204	CcSEcCtD
Ketoprofen—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000658	0.00203	CcSEcCtD
Ketoprofen—Asthenia—Fludarabine—lymphatic system cancer	0.000657	0.00203	CcSEcCtD
Ketoprofen—Rash—Teniposide—lymphatic system cancer	0.000657	0.00203	CcSEcCtD
Ketoprofen—Dermatitis—Teniposide—lymphatic system cancer	0.000657	0.00203	CcSEcCtD
Ketoprofen—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000654	0.00202	CcSEcCtD
Ketoprofen—Headache—Teniposide—lymphatic system cancer	0.000653	0.00202	CcSEcCtD
Ketoprofen—Pruritus—Fludarabine—lymphatic system cancer	0.000648	0.002	CcSEcCtD
Ketoprofen—Anorexia—Bleomycin—lymphatic system cancer	0.00064	0.00198	CcSEcCtD
Ketoprofen—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000635	0.00196	CcSEcCtD
Ketoprofen—Anaemia—Vincristine—lymphatic system cancer	0.000634	0.00196	CcSEcCtD
Ketoprofen—Photosensitivity—Methotrexate—lymphatic system cancer	0.000629	0.00195	CcSEcCtD
Ketoprofen—Diarrhoea—Fludarabine—lymphatic system cancer	0.000627	0.00194	CcSEcCtD
Ketoprofen—Convulsion—Carmustine—lymphatic system cancer	0.000623	0.00192	CcSEcCtD
Ketoprofen—Hypertension—Carmustine—lymphatic system cancer	0.00062	0.00192	CcSEcCtD
Ketoprofen—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00062	0.00192	CcSEcCtD
Ketoprofen—Nausea—Teniposide—lymphatic system cancer	0.000619	0.00191	CcSEcCtD
Ketoprofen—Anaemia—Mitoxantrone—lymphatic system cancer	0.000617	0.00191	CcSEcCtD
Ketoprofen—Vertigo—Vincristine—lymphatic system cancer	0.000616	0.0019	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000612	0.00189	CcSEcCtD
Ketoprofen—Myalgia—Carmustine—lymphatic system cancer	0.000612	0.00189	CcSEcCtD
Ketoprofen—Anxiety—Carmustine—lymphatic system cancer	0.00061	0.00188	CcSEcCtD
Ketoprofen—Paraesthesia—Bleomycin—lymphatic system cancer	0.000603	0.00186	CcSEcCtD
Ketoprofen—Malaise—Mitoxantrone—lymphatic system cancer	0.000602	0.00186	CcSEcCtD
Ketoprofen—Dyspnoea—Bleomycin—lymphatic system cancer	0.000599	0.00185	CcSEcCtD
Ketoprofen—Convulsion—Vincristine—lymphatic system cancer	0.000594	0.00184	CcSEcCtD
Ketoprofen—Hypertension—Vincristine—lymphatic system cancer	0.000592	0.00183	CcSEcCtD
Ketoprofen—Confusional state—Carmustine—lymphatic system cancer	0.000591	0.00183	CcSEcCtD
Ketoprofen—Oedema—Carmustine—lymphatic system cancer	0.000586	0.00181	CcSEcCtD
Ketoprofen—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000586	0.00181	CcSEcCtD
Ketoprofen—Decreased appetite—Bleomycin—lymphatic system cancer	0.000584	0.00181	CcSEcCtD
Ketoprofen—Myalgia—Vincristine—lymphatic system cancer	0.000584	0.0018	CcSEcCtD
Ketoprofen—Visual disturbance—Methotrexate—lymphatic system cancer	0.000583	0.0018	CcSEcCtD
Ketoprofen—Infection—Carmustine—lymphatic system cancer	0.000583	0.0018	CcSEcCtD
Ketoprofen—Vomiting—Fludarabine—lymphatic system cancer	0.000583	0.0018	CcSEcCtD
Ketoprofen—Convulsion—Mitoxantrone—lymphatic system cancer	0.000579	0.00179	CcSEcCtD
Ketoprofen—Rash—Fludarabine—lymphatic system cancer	0.000578	0.00179	CcSEcCtD
Ketoprofen—Dermatitis—Fludarabine—lymphatic system cancer	0.000577	0.00178	CcSEcCtD
Ketoprofen—Hypertension—Mitoxantrone—lymphatic system cancer	0.000577	0.00178	CcSEcCtD
Ketoprofen—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000574	0.00177	CcSEcCtD
Ketoprofen—Headache—Fludarabine—lymphatic system cancer	0.000574	0.00177	CcSEcCtD
Ketoprofen—Tachycardia—Carmustine—lymphatic system cancer	0.000572	0.00177	CcSEcCtD
Ketoprofen—Myalgia—Mitoxantrone—lymphatic system cancer	0.000569	0.00176	CcSEcCtD
Ketoprofen—Anxiety—Mitoxantrone—lymphatic system cancer	0.000567	0.00175	CcSEcCtD
Ketoprofen—Discomfort—Mitoxantrone—lymphatic system cancer	0.000562	0.00174	CcSEcCtD
Ketoprofen—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00056	0.00173	CcSEcCtD
Ketoprofen—Oedema—Vincristine—lymphatic system cancer	0.00056	0.00173	CcSEcCtD
Ketoprofen—Anorexia—Carmustine—lymphatic system cancer	0.000559	0.00173	CcSEcCtD
Ketoprofen—Infection—Vincristine—lymphatic system cancer	0.000556	0.00172	CcSEcCtD
Ketoprofen—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000554	0.00171	CcSEcCtD
Ketoprofen—Confusional state—Mitoxantrone—lymphatic system cancer	0.00055	0.0017	CcSEcCtD
Ketoprofen—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000548	0.00169	CcSEcCtD
Ketoprofen—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000545	0.00169	CcSEcCtD
Ketoprofen—Oedema—Mitoxantrone—lymphatic system cancer	0.000545	0.00169	CcSEcCtD
Ketoprofen—Nausea—Fludarabine—lymphatic system cancer	0.000544	0.00168	CcSEcCtD
Ketoprofen—Infection—Mitoxantrone—lymphatic system cancer	0.000542	0.00167	CcSEcCtD
Ketoprofen—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000541	0.00167	CcSEcCtD
Ketoprofen—Shock—Mitoxantrone—lymphatic system cancer	0.000536	0.00166	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000534	0.00165	CcSEcCtD
Ketoprofen—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000534	0.00165	CcSEcCtD
Ketoprofen—Urticaria—Bleomycin—lymphatic system cancer	0.000534	0.00165	CcSEcCtD
Ketoprofen—Anorexia—Vincristine—lymphatic system cancer	0.000534	0.00165	CcSEcCtD
Ketoprofen—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000532	0.00164	CcSEcCtD
Ketoprofen—Insomnia—Carmustine—lymphatic system cancer	0.00053	0.00164	CcSEcCtD
Ketoprofen—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000527	0.00163	CcSEcCtD
Ketoprofen—Paraesthesia—Carmustine—lymphatic system cancer	0.000527	0.00163	CcSEcCtD
Ketoprofen—Dyspnoea—Carmustine—lymphatic system cancer	0.000523	0.00162	CcSEcCtD
Ketoprofen—Somnolence—Carmustine—lymphatic system cancer	0.000521	0.00161	CcSEcCtD
Ketoprofen—Anorexia—Mitoxantrone—lymphatic system cancer	0.00052	0.00161	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00051	0.00158	CcSEcCtD
Ketoprofen—Decreased appetite—Carmustine—lymphatic system cancer	0.00051	0.00158	CcSEcCtD
Ketoprofen—Insomnia—Vincristine—lymphatic system cancer	0.000506	0.00156	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000506	0.00156	CcSEcCtD
Ketoprofen—Paraesthesia—Vincristine—lymphatic system cancer	0.000503	0.00155	CcSEcCtD
Ketoprofen—Constipation—Carmustine—lymphatic system cancer	0.000501	0.00155	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000498	0.00154	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000497	0.00154	CcSEcCtD
Ketoprofen—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000495	0.00153	CcSEcCtD
Ketoprofen—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00049	0.00151	CcSEcCtD
Ketoprofen—Decreased appetite—Vincristine—lymphatic system cancer	0.000487	0.0015	CcSEcCtD
Ketoprofen—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000486	0.0015	CcSEcCtD
Ketoprofen—Somnolence—Mitoxantrone—lymphatic system cancer	0.000485	0.0015	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000483	0.00149	CcSEcCtD
Ketoprofen—Feeling abnormal—Carmustine—lymphatic system cancer	0.000483	0.00149	CcSEcCtD
Ketoprofen—Fatigue—Vincristine—lymphatic system cancer	0.000483	0.00149	CcSEcCtD
Ketoprofen—Asthenia—Bleomycin—lymphatic system cancer	0.000482	0.00149	CcSEcCtD
Ketoprofen—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00048	0.00148	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00048	0.00148	CcSEcCtD
Ketoprofen—Constipation—Vincristine—lymphatic system cancer	0.000479	0.00148	CcSEcCtD
Ketoprofen—Asthma—Methotrexate—lymphatic system cancer	0.000478	0.00148	CcSEcCtD
Ketoprofen—Pruritus—Bleomycin—lymphatic system cancer	0.000475	0.00147	CcSEcCtD
Ketoprofen—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000474	0.00146	CcSEcCtD
Ketoprofen—Fatigue—Mitoxantrone—lymphatic system cancer	0.00047	0.00145	CcSEcCtD
Ketoprofen—Pancreatitis—Methotrexate—lymphatic system cancer	0.000468	0.00145	CcSEcCtD
Ketoprofen—Constipation—Mitoxantrone—lymphatic system cancer	0.000466	0.00144	CcSEcCtD
Ketoprofen—Abdominal pain—Carmustine—lymphatic system cancer	0.000464	0.00143	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000458	0.00141	CcSEcCtD
Ketoprofen—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000449	0.00139	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000446	0.00138	CcSEcCtD
Ketoprofen—Abdominal pain—Vincristine—lymphatic system cancer	0.000443	0.00137	CcSEcCtD
Ketoprofen—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00044	0.00136	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000436	0.00135	CcSEcCtD
Ketoprofen—Urticaria—Mitoxantrone—lymphatic system cancer	0.000433	0.00134	CcSEcCtD
Ketoprofen—Hypersensitivity—Carmustine—lymphatic system cancer	0.000432	0.00134	CcSEcCtD
Ketoprofen—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000431	0.00133	CcSEcCtD
Ketoprofen—Vomiting—Bleomycin—lymphatic system cancer	0.000427	0.00132	CcSEcCtD
Ketoprofen—Drowsiness—Methotrexate—lymphatic system cancer	0.000426	0.00132	CcSEcCtD
Ketoprofen—Rash—Bleomycin—lymphatic system cancer	0.000424	0.00131	CcSEcCtD
Ketoprofen—Dermatitis—Bleomycin—lymphatic system cancer	0.000423	0.00131	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000422	0.00131	CcSEcCtD
Ketoprofen—Asthenia—Carmustine—lymphatic system cancer	0.000421	0.0013	CcSEcCtD
Ketoprofen—Renal failure—Methotrexate—lymphatic system cancer	0.000419	0.00129	CcSEcCtD
Ketoprofen—Stomatitis—Methotrexate—lymphatic system cancer	0.000415	0.00128	CcSEcCtD
Ketoprofen—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000414	0.00128	CcSEcCtD
Ketoprofen—Hypersensitivity—Vincristine—lymphatic system cancer	0.000412	0.00127	CcSEcCtD
Ketoprofen—Sweating—Methotrexate—lymphatic system cancer	0.000408	0.00126	CcSEcCtD
Ketoprofen—Haematuria—Methotrexate—lymphatic system cancer	0.000406	0.00126	CcSEcCtD
Ketoprofen—Epistaxis—Methotrexate—lymphatic system cancer	0.000402	0.00124	CcSEcCtD
Ketoprofen—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000402	0.00124	CcSEcCtD
Ketoprofen—Asthenia—Vincristine—lymphatic system cancer	0.000402	0.00124	CcSEcCtD
Ketoprofen—Diarrhoea—Carmustine—lymphatic system cancer	0.000401	0.00124	CcSEcCtD
Ketoprofen—Nausea—Bleomycin—lymphatic system cancer	0.000399	0.00123	CcSEcCtD
Ketoprofen—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000397	0.00123	CcSEcCtD
Ketoprofen—Asthenia—Mitoxantrone—lymphatic system cancer	0.000391	0.00121	CcSEcCtD
Ketoprofen—Dizziness—Carmustine—lymphatic system cancer	0.000388	0.0012	CcSEcCtD
Ketoprofen—Diarrhoea—Vincristine—lymphatic system cancer	0.000383	0.00118	CcSEcCtD
Ketoprofen—Hepatitis—Methotrexate—lymphatic system cancer	0.000382	0.00118	CcSEcCtD
Ketoprofen—Pharyngitis—Methotrexate—lymphatic system cancer	0.000379	0.00117	CcSEcCtD
Ketoprofen—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000373	0.00115	CcSEcCtD
Ketoprofen—Vomiting—Carmustine—lymphatic system cancer	0.000373	0.00115	CcSEcCtD
Ketoprofen—Dizziness—Vincristine—lymphatic system cancer	0.00037	0.00114	CcSEcCtD
Ketoprofen—Rash—Carmustine—lymphatic system cancer	0.00037	0.00114	CcSEcCtD
Ketoprofen—Dermatitis—Carmustine—lymphatic system cancer	0.000369	0.00114	CcSEcCtD
Ketoprofen—Visual impairment—Methotrexate—lymphatic system cancer	0.000368	0.00114	CcSEcCtD
Ketoprofen—Headache—Carmustine—lymphatic system cancer	0.000367	0.00114	CcSEcCtD
Ketoprofen—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000361	0.00112	CcSEcCtD
Ketoprofen—Tinnitus—Methotrexate—lymphatic system cancer	0.000356	0.0011	CcSEcCtD
Ketoprofen—Vomiting—Vincristine—lymphatic system cancer	0.000356	0.0011	CcSEcCtD
Ketoprofen—Rash—Vincristine—lymphatic system cancer	0.000353	0.00109	CcSEcCtD
Ketoprofen—Dermatitis—Vincristine—lymphatic system cancer	0.000353	0.00109	CcSEcCtD
Ketoprofen—Headache—Vincristine—lymphatic system cancer	0.000351	0.00108	CcSEcCtD
Ketoprofen—Nausea—Carmustine—lymphatic system cancer	0.000348	0.00108	CcSEcCtD
Ketoprofen—Vomiting—Mitoxantrone—lymphatic system cancer	0.000347	0.00107	CcSEcCtD
Ketoprofen—Rash—Mitoxantrone—lymphatic system cancer	0.000344	0.00106	CcSEcCtD
Ketoprofen—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000343	0.00106	CcSEcCtD
Ketoprofen—Chills—Methotrexate—lymphatic system cancer	0.000343	0.00106	CcSEcCtD
Ketoprofen—Headache—Mitoxantrone—lymphatic system cancer	0.000342	0.00106	CcSEcCtD
Ketoprofen—Alopecia—Methotrexate—lymphatic system cancer	0.000338	0.00104	CcSEcCtD
Ketoprofen—Erythema—Methotrexate—lymphatic system cancer	0.000333	0.00103	CcSEcCtD
Ketoprofen—Nausea—Vincristine—lymphatic system cancer	0.000333	0.00103	CcSEcCtD
Ketoprofen—Dysgeusia—Methotrexate—lymphatic system cancer	0.000326	0.00101	CcSEcCtD
Ketoprofen—Nausea—Mitoxantrone—lymphatic system cancer	0.000324	0.001	CcSEcCtD
Ketoprofen—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000309	0.000954	CcSEcCtD
Ketoprofen—Anaemia—Methotrexate—lymphatic system cancer	0.000308	0.000951	CcSEcCtD
Ketoprofen—Malaise—Methotrexate—lymphatic system cancer	0.0003	0.000928	CcSEcCtD
Ketoprofen—Vertigo—Methotrexate—lymphatic system cancer	0.000299	0.000924	CcSEcCtD
Ketoprofen—Convulsion—Methotrexate—lymphatic system cancer	0.000288	0.000891	CcSEcCtD
Ketoprofen—Myalgia—Methotrexate—lymphatic system cancer	0.000283	0.000876	CcSEcCtD
Ketoprofen—Discomfort—Methotrexate—lymphatic system cancer	0.00028	0.000865	CcSEcCtD
Ketoprofen—Confusional state—Methotrexate—lymphatic system cancer	0.000274	0.000847	CcSEcCtD
Ketoprofen—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000272	0.00084	CcSEcCtD
Ketoprofen—Infection—Methotrexate—lymphatic system cancer	0.00027	0.000834	CcSEcCtD
Ketoprofen—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000266	0.000822	CcSEcCtD
Ketoprofen—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000263	0.000812	CcSEcCtD
Ketoprofen—Anorexia—Methotrexate—lymphatic system cancer	0.000259	0.0008	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000247	0.000765	CcSEcCtD
Ketoprofen—Insomnia—Methotrexate—lymphatic system cancer	0.000246	0.000759	CcSEcCtD
Ketoprofen—Paraesthesia—Methotrexate—lymphatic system cancer	0.000244	0.000754	CcSEcCtD
Ketoprofen—Dyspnoea—Methotrexate—lymphatic system cancer	0.000242	0.000748	CcSEcCtD
Ketoprofen—Somnolence—Methotrexate—lymphatic system cancer	0.000241	0.000746	CcSEcCtD
Ketoprofen—Dyspepsia—Methotrexate—lymphatic system cancer	0.000239	0.000739	CcSEcCtD
Ketoprofen—Decreased appetite—Methotrexate—lymphatic system cancer	0.000236	0.00073	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000235	0.000725	CcSEcCtD
Ketoprofen—Fatigue—Methotrexate—lymphatic system cancer	0.000234	0.000724	CcSEcCtD
Ketoprofen—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000224	0.000692	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000222	0.000687	CcSEcCtD
Ketoprofen—Urticaria—Methotrexate—lymphatic system cancer	0.000216	0.000667	CcSEcCtD
Ketoprofen—Abdominal pain—Methotrexate—lymphatic system cancer	0.000215	0.000664	CcSEcCtD
Ketoprofen—Hypersensitivity—Methotrexate—lymphatic system cancer	0.0002	0.000619	CcSEcCtD
Ketoprofen—Asthenia—Methotrexate—lymphatic system cancer	0.000195	0.000602	CcSEcCtD
Ketoprofen—Pruritus—Methotrexate—lymphatic system cancer	0.000192	0.000594	CcSEcCtD
Ketoprofen—Diarrhoea—Methotrexate—lymphatic system cancer	0.000186	0.000574	CcSEcCtD
Ketoprofen—Dizziness—Methotrexate—lymphatic system cancer	0.00018	0.000555	CcSEcCtD
Ketoprofen—Vomiting—Methotrexate—lymphatic system cancer	0.000173	0.000534	CcSEcCtD
Ketoprofen—Rash—Methotrexate—lymphatic system cancer	0.000171	0.000529	CcSEcCtD
Ketoprofen—Dermatitis—Methotrexate—lymphatic system cancer	0.000171	0.000529	CcSEcCtD
Ketoprofen—Headache—Methotrexate—lymphatic system cancer	0.00017	0.000526	CcSEcCtD
Ketoprofen—Nausea—Methotrexate—lymphatic system cancer	0.000161	0.000499	CcSEcCtD
